Skip to Main Content

On this week’s episode of “The Readout LOUD,” our STAT colleague Nicholas Florko joins us to explain what it means to be a reporter who writes about the commercial determinants of health. Hint: Florko’s most recent stories focused on weed, vapes and raw milk. And instead of being chained to a desk, he often drives around to convenience stores and buy bad stuff — all in the name of good journalism.

Also this week, co-hosts Adam Feuerstein and Allison DeAngelis chat about Pfizer’s Duchenne gene therapy setback, the likely approval of a new treatment for Alzheimer’s disease, and Bob Langer’s most recent startup.


To learn more about Florko’s coverage of vapes, look here; his story on buying raw milk — and why you shouldn’t do it, too — can be found here. To read about the failure of Pfizer’s gene therapy study, go here, and a recap of the FDA advisory panel that reviewed Eli Lilly’s Alzheimer’s drug can be found here. Bob Langer’s new startup details are here.

STAT+ Exclusive Story


This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Already have an account? Log in



Totals $468 per year

$39/month Get Started

Totals $468 per year



for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month



Save 15%

$399/year Get Started

Save 15%

11+ Users


Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users


Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.


STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect

To submit a correction request, please visit our Contact Us page.